Variable | Hazard ratio | 95% CI | p value |
---|---|---|---|
Age at diagnosis | 1.0116 | 1.0061–1.0172 | < 0.001*** |
Race | |||
 White | Reference |  |  |
 Black | 1.1698 | 1.0225–1.3383 | 0.022* |
 Other | 0.8481 | 0.6698–1.0739 | 0.171 |
Marital status | |||
 Married | Reference |  |  |
 Single | 1.2181 | 1.0436–1.4217 | 0.012* |
 SDW | 1.2965 | 1.1230–1.4969 | < 0.001*** |
 Other | 1.2816 | 0.9740–1.6863 | 0.076 |
Insurance record | |||
 Yes | Reference |  |  |
 No | 1.4851 | 1.1367–1.9404 | 0.004** |
Tumor size | |||
 ≤ 50 mm | Reference |  |  |
 > 50 mm | 1.4861 | 1.2674–1.7425 | < 0.001*** |
 Unknown | 1.3345 | 1.0802–1.6487 | 0.007** |
Pathological grade | |||
 I | Reference |  |  |
 II | 1.3135 | 0.7662–2.2518 | 0.321 |
 III | 7.3773 | 4.5441–11.9771 | < 0.001*** |
 IV | 7.0185 | 4.3528–11.3165 | < 0.001*** |
Histological type | |||
 Sarcoma | Reference |  |  |
 Leiomyosarcoma | 0.6550 | 0.4839–0.8866 | 0.006** |
 Adenosarcoma | 0.6288 | 0.3919–1.0089 | 0.054 |
 Stromal sarcoma | 0.9274 | 0.6623–1.2984 | 0.661 |
 Carcinosarcoma | 0.6099 | 0.4535–0.8202 | 0.001** |
SEER stage | |||
 Localized | Reference |  |  |
 Regional | 1.8809 | 1.3831–2.5580 | < 0.001*** |
 Distant | 2.5199 | 1.6708–3.8005 | < 0.001*** |
AJCC stage | |||
 I | Reference |  |  |
 II | 1.0136 | 0.7096–1.4478 | 0.941 |
 III | 1.7459 | 1.2843–2.3735 | < 0.001*** |
 IV | 2.2275 | 1.4818–3.3484 | < 0.001*** |
Surgery status | |||
 Yes | Reference |  |  |
 No/unknown | 2.7559 | 2.2503–3.3751 | < 0.001*** |
Radiotherapy status | |||
 Yes | Reference |  |  |
 No/unknown | 1.3267 | 1.1567–1.5216 | < 0.001*** |
Chemotherapy status | |||
 Yes | Reference |  |  |
 No/unknown | 1.5355 | 1.3509–1.7453 | < 0.001*** |